Amber Implants develops next-generation implants for treating vertebral fractures, addressing unmet clinical needs in this area. The company focuses on optimizing products and procedures to improve patient well-being following injuries like VCFs and burst fractures. Their offerings aim to provide a complete treatment alternative where existing methods often result in significant side effects.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Vertebral compression fractures (VCFs), often caused by osteoporosis, trauma, or tumors, affect over 1.5 million people annually, leading to severe back pain, limited mobility, and height loss. Existing non-surgical treatments for VCFs are associated with high morbidity and serious side effects, such as those caused by the injection of PMMA bone cement. There is a need for safer and more effective solutions to stabilize the spine and improve pain control in patients with VCFs.
Solution
Amber Implants offers the VCFix® Spinal System, a vertebral body augmentation technology designed to provide a new treatment option for a wide variety of vertebral fractures. The VCFix® system aims to improve pain control and stabilize the spine in patients suffering from vertebral compression fractures. By addressing unmet clinical needs and prioritizing patient well-being, Amber Implants focuses on optimizing products and procedures to provide a complete treatment for vertebral fractures.
Target Audience
The primary target audience includes individuals suffering from vertebral compression fractures due to osteoporosis, trauma, tumors, or other bone diseases.
Features
- Vertebral body augmentation system for improved pain control
- Designed to stabilize the spine in patients with vertebral compression fractures